Streetbeat News

Acquisitions Mergers

MDB

MariaDB has received an unsolicited non-binding indicative proposal from Runa Capital II to acquire all issued ordinary shares not already owned by Runa.

Portfolio Pulse from Bill Haddad

September 18, 2023 | 12:06 pm

GEHC

GE HealthCare (NASDAQ:GEHC) has been awarded a $44 million grant from the Bill & Melinda Gates Foundation to develop AI-assisted ultrasound technology aimed at improving healthcare outcomes in low-and-middle-income countries. The technology will be designed by Caption Health, a medical AI company acquired by GE HealthCare in 2023. The grant will facilitate the development of AI-assisted applications and tools to enable healthcare professionals with less experience to perform quick and accurate ultrasound scans.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 12:05 pm

TIO

Tingo Group has appointed Dozy Mmobuosi and Kenneth Denos as interim co-CEOs, following the planned departure of Darren Mercer after the merger of MICT and Tingo, Inc. The company has also appointed Jamal Kurshid as an independent member of the Board of Directors, and Deputy Chairman John Scott will become Chairman.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 12:03 pm

RSSS

Research Solutions, Inc. (NASDAQ:RSSS) has entered into a cooperation agreement with Peter Derycz, Bristol Investment Fund, Ltd., Bristol Capital Advisors, LLC and Paul Kessler, who collectively own 5,921,930 shares of the company's common stock. As part of the agreement, Derycz's employment will be terminated and he will resign from the company's board of directors. The company will appoint a new independent director to fill the vacancy. The Investor Group has agreed to withdraw its notice of intent to nominate director candidates for the 2023 Annual Meeting of Shareholders and cease all solicitations of proxies and other activities in connection with the meeting.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 12:02 pm

ARM

SFTBF

SFTBY

Following the successful IPO of Arm Holding Plc, SoftBank Group Corp is considering investing in OpenAI, the creator of ChatGPT. SoftBank is also contemplating substantial investments in OpenAI's direct competitors. The company is also considering alternative deals, such as the acquisition of British AI chip maker Graphcore.

Portfolio Pulse from Vandana Singh

September 18, 2023 | 11:59 am

FLGC

LFSWF

Flora Growth Corp. (NASDAQ:FLGC) has agreed to acquire Australian Vaporizes Pty Limited from Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF) for $1.7 million in shares. The deal is expected to close in Q4 2023. Australian Vaporizes is expected to contribute $5.2 million in annual revenues, $1.2 million in gross margins, and $500,000 in net income to Flora. The acquisition is expected to drive synergies with Flora's existing brands, including selling Vessel Brand products in Australia.

Portfolio Pulse from Nina Zdinjak

September 18, 2023 | 11:43 am

CCCS

Private equity firm Advent International is reportedly exploring a sale of CCC Intelligent Solutions, which has a market value of $7.1 billion.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 11:41 am

NEM

Newmont Corporation has received clearances from Australia's Foreign Investment Review Board and Japan's Fair Trade Commission to proceed with its proposed acquisition of Newcrest Mining Limited. The acquisition is expected to close in the fourth quarter of this year. The combined company is anticipated to generate annual pre-tax synergies of $500 million, expected to be achieved within the first 24 months, while also targeting at least $2 billion in cash improvements through portfolio optimization in the first two years after closing.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 11:34 am

DIS

Disney India is reportedly in talks for a potential sale, with companies including Reliance showing interest. The details of the deal are not yet disclosed.

Portfolio Pulse from Charles Gross

September 18, 2023 | 11:19 am

GSK

The FDA has approved GSK plc's (NYSE:GSK) Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis in adults with anemia. GSK acquired the blood cancer therapy from Sierra Oncology Inc. for $1.9 billion. This comes as a surprise after the European Medicines Agency's human medicines committee recommended not renewing the conditional marketing authorization for Blenrep, another GSK drug. GSK shares are up 1.23% in premarket trading.

Portfolio Pulse from Vandana Singh

September 18, 2023 | 10:54 am